ATE53496T1 - Immunoglobulinkonjugate. - Google Patents

Immunoglobulinkonjugate.

Info

Publication number
ATE53496T1
ATE53496T1 AT84302004T AT84302004T ATE53496T1 AT E53496 T1 ATE53496 T1 AT E53496T1 AT 84302004 T AT84302004 T AT 84302004T AT 84302004 T AT84302004 T AT 84302004T AT E53496 T1 ATE53496 T1 AT E53496T1
Authority
AT
Austria
Prior art keywords
immunoglobulin
sub
immunoglobulin conjugates
conjugates
ocoxco
Prior art date
Application number
AT84302004T
Other languages
English (en)
Inventor
George Joseph Cullinan
George Ferdinand Rowland
Robin George Simmonds
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Application granted granted Critical
Publication of ATE53496T1 publication Critical patent/ATE53496T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6805—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Materials For Medical Uses (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT84302004T 1983-03-30 1984-03-26 Immunoglobulinkonjugate. ATE53496T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8308857 1983-03-30
EP84302004A EP0121388B1 (de) 1983-03-30 1984-03-26 Immunoglobulinkonjugate

Publications (1)

Publication Number Publication Date
ATE53496T1 true ATE53496T1 (de) 1990-06-15

Family

ID=10540516

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84302004T ATE53496T1 (de) 1983-03-30 1984-03-26 Immunoglobulinkonjugate.

Country Status (24)

Country Link
US (1) US4845200A (de)
EP (1) EP0121388B1 (de)
JP (1) JPS59190924A (de)
KR (1) KR890002634B1 (de)
AT (1) ATE53496T1 (de)
AU (1) AU570963B2 (de)
BG (1) BG42837A3 (de)
CA (1) CA1210696A (de)
DE (1) DE3482444D1 (de)
DK (1) DK167884A (de)
EG (1) EG16175A (de)
ES (1) ES531081A0 (de)
FI (1) FI80383C (de)
GB (1) GB2137210B (de)
GR (1) GR79899B (de)
HU (1) HU191647B (de)
IE (1) IE57218B1 (de)
IL (1) IL71366A (de)
NZ (1) NZ207675A (de)
PH (1) PH23222A (de)
PL (1) PL144887B1 (de)
PT (1) PT78322B (de)
SU (1) SU1362404A3 (de)
ZA (1) ZA842347B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86157A1 (fr) * 1985-11-12 1987-06-26 Omnichem Sa Nouveau procede de fabrication de conjugues de la vinblastine et de ses derives
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
US4667030A (en) * 1985-06-17 1987-05-19 Eli Lilly And Company Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids
FI860456A (fi) * 1985-07-16 1987-01-17 Huhtamaeki Oy Laeaeketehdas Le Bis-indolalkaloiders proteinkonjugat, bis-indolalkaloider, deras framstaellning och anvaendning.
CA1289880C (en) * 1985-12-06 1991-10-01 Jeffrey L. Winkelhake Anti-human ovarian cancer immunotoxins and methods of use thereof
CA1287578C (en) * 1985-12-06 1991-08-13 Michael J. Bjorn Anti-human ovarian cancer immunotoxins and methods of use thereof
EP0232693A3 (de) * 1985-12-16 1988-04-06 La Region Wallonne Konjugate des Vinblastins und seiner Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US4801688A (en) * 1986-05-27 1989-01-31 Eli Lilly And Company Hydrazone immunoglobulin conjugates
ZA873600B (en) * 1986-05-27 1988-12-28 Lilly Co Eli Immunoglobulin conjugates
IL84842A0 (en) * 1986-12-24 1988-06-30 Lilly Co Eli Immunoglobulin conjugates
US4814438A (en) * 1986-12-24 1989-03-21 Eli Lilly And Company Immunoglobulin conjugates of 2',2'-difluronucleosides
US4994558A (en) * 1986-12-24 1991-02-19 Eli Lilly And Company Immunoglobulin conjugates
PT89504A (pt) * 1988-01-27 1989-10-04 Lilly Co Eli Processo para a preparacao de conjugados de anticorpos com hidrazidas de vinca
FR2626882B1 (fr) * 1988-02-08 1991-11-08 Ire Celltarg Sa Conjugues de derives de vinca comportant une chaine detergente en position c-3
IT1219874B (it) * 1988-03-18 1990-05-24 Fidia Farmaceutici Utilizzazione del fattore di crescita nervoso umano e sue composizioni farmaceutiche
US5028697A (en) * 1988-08-08 1991-07-02 Eli Lilly And Company Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers
US5094849A (en) * 1988-08-08 1992-03-10 Eli Lilly And Company Cytotoxic antibody conjugates of hydrazide derivatized vinca analogs via simple organic linkers
US5006652A (en) * 1988-08-08 1991-04-09 Eli Lilly And Company Intermediates for antibody-vinca drug conjugates
US5144012A (en) * 1988-08-08 1992-09-01 Eli Lilly And Company Cytotoxic drug conjugates
US5010176A (en) * 1988-11-10 1991-04-23 Eli Lilly And Company Antibody-drug conjugates
DE4122210C2 (de) * 1991-07-04 1999-04-01 Deutsches Krebsforsch Konjugate aus tumoraktiver Verbindung und Serumalbumin sowie Verfahren zu deren Herstellung und ihre Verwendung
US7097839B1 (en) * 1993-10-26 2006-08-29 Thomas Jefferson University ST receptor binding compounds and methods of using the same
US5879656A (en) * 1993-10-26 1999-03-09 Thomas Jefferson University Methods of treating metastatic colorectal cancer with ST receptor binding compounds
CN110790777B (zh) * 2019-10-24 2021-05-25 广州白云山汉方现代药业有限公司 一种长春新碱类化合物杂质及其制备方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4045420A (en) * 1973-05-29 1977-08-30 Syva Company Non-oxo-carbonyl containing benzoyl ecgonine and cocaine compounds polypeptide and derivatives thereof
US4026879A (en) * 1976-03-23 1977-05-31 Hoffmann-La Roche Inc. Antigen-containing propranolol derivatives
US4069105A (en) * 1977-03-03 1978-01-17 Syva Company Lidocaine antigens and antibodies
US4243654A (en) * 1978-09-11 1981-01-06 Syva Company Oxazepam derivatives for immunoassay reagents
US4315851A (en) * 1978-12-29 1982-02-16 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition having antitumor activity
US4223013A (en) * 1978-12-29 1980-09-16 Syva Company Amitriptyline conjugates to antigenic proteins and enzymes
FI820020L (fi) * 1981-01-12 1982-07-13 Lilly Industries Ltd Immunoglobulinkonjugater
FR2516794B1 (fr) * 1981-11-20 1985-10-25 Sanofi Sa Nouveaux medicaments anticancereux pour le traitement des leucemies t constitues de la chaine a de la ricine et d'un anticorps monoclonal specifique
JPS59116229A (ja) * 1982-12-24 1984-07-05 Teijin Ltd 細胞毒性複合体を活性成分とする癌治療用剤およびその製造法
DK167984A (da) * 1983-03-30 1984-10-01 Lilly Industries Ltd Alkaloidderivater

Also Published As

Publication number Publication date
FI841260A (fi) 1984-10-01
GB2137210B (en) 1986-11-19
PL246931A1 (en) 1985-03-26
PH23222A (en) 1989-06-06
CA1210696A (en) 1986-09-02
HUT34045A (en) 1985-01-28
DK167884D0 (da) 1984-03-26
FI841260A0 (fi) 1984-03-29
FI80383C (fi) 1990-06-11
EP0121388A3 (en) 1986-11-12
IE840772L (en) 1984-09-30
ES8506708A1 (es) 1985-07-16
DE3482444D1 (de) 1990-07-19
EG16175A (en) 1986-12-30
HU191647B (en) 1987-03-30
KR890002634B1 (ko) 1989-07-21
EP0121388A2 (de) 1984-10-10
GB2137210A (en) 1984-10-03
IL71366A0 (en) 1984-06-29
PL144887B1 (en) 1988-07-30
AU2614384A (en) 1984-10-04
KR840008286A (ko) 1984-12-14
ZA842347B (en) 1985-06-26
GB8407766D0 (en) 1984-05-02
FI80383B (fi) 1990-02-28
US4845200A (en) 1989-07-04
SU1362404A3 (ru) 1987-12-23
IE57218B1 (en) 1992-06-03
IL71366A (en) 1988-10-31
NZ207675A (en) 1986-07-11
JPS59190924A (ja) 1984-10-29
GR79899B (de) 1984-10-31
PT78322A (en) 1984-04-01
DK167884A (da) 1984-10-01
PT78322B (en) 1986-08-08
EP0121388B1 (de) 1990-06-13
BG42837A3 (en) 1988-02-15
AU570963B2 (en) 1988-03-31
ES531081A0 (es) 1985-07-16

Similar Documents

Publication Publication Date Title
ATE53496T1 (de) Immunoglobulinkonjugate.
DE3584559D1 (de) Therapeutische antikoerpermittelkonjugate.
NO164485C (no) Mild, flytende oppvaskmiddelblanding.
DK283588A (da) Monoklonalt antistof mod ovariecancerceller
SE8800886D0 (sv) Immunoglobulin conjugates
NO862920D0 (no) Onkofetale spesifikke monoklonale antistoffer, fremgangsmaate for fremstilling og anvendelse.
FI883723A (fi) Monoklonala maenniskoantikroppar och dessa innehaollande terapeutiska kompositioner mot infektionssjukdomar.
NO873488D0 (no) Monoklonale antistoffer.
BE896981A (nl) Bestralings bank, tunnel
NO854958L (no) Bindeanordning.
FI843033A0 (fi) Propp.
IT8419209A0 (it) Dispositivo di strozzatura per tubazioni.
NO862423L (no) Beleggingsmateriale for veier, plasser o.l.
ATE68974T1 (de) Therapeutische antikoerpermittelkonjugate.
ES280142Y (es) Sierra troceadora perfeccionada.
ATE52269T1 (de) In wasser quellfaehige kautschukmischung.
IT8483441A0 (it) Profilatrice-trasferitrice semovente per massicciata.
NO882162D0 (no) Monoklonale antistoffer mot ovariekreftceller (ovb-3).
IT8460399V0 (it) Snodatore per catename.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee